No profile data available.
Cytosorbents Corporation (CTSO) is a healthcare company in the additional specific healthcare equipment industry, based in Princeton, United States, with about 129 full-time employees.
It reported revenue of $37.06 million for fiscal year 2025, up 4.1% from fiscal year 2024, and net income of -$8.20 million. ALL Other Countries was its largest region in fiscal year 2025, with 68% of revenue. Its market capitalization was $12.49 million as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 5, 2026.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally.
Cytosorbents reported $37.06 million in revenue for fiscal year 2025, up 4.1% from $35.59 million in fiscal year 2024.
ALL Other Countries: 68% of revenue by region in fiscal year 2025, followed by Germany (32%).
$12.49 million as of October 5, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include Envoy Medical, Inc. (COCH), Polyrizon Ltd. (PLRZ), Radiopharm Theranostics Limited (RADX), Zeo ScientifiX, Inc. (ZEOX).